Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

PSMB4 promotes multiple myeloma cell growth by activating NF-κB-miR-21 signaling

Journal Article · · Biochemical and Biophysical Research Communications
;  [1];  [2];  [3];  [4];  [1]
  1. Department of Hematology, Navy General Hospital, Beijing 100048 (China)
  2. School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006 (China)
  3. Department of Medical Oncology, Jinling Hospital, Nanjing 210002 (China)
  4. Department of Stomatology, Jinling Hospital, Nanjing 210002 (China)

Proteasomal subunit PSMB4, was recently identified as potential cancer driver genes in several tumors. However, the regulatory mechanism of PSMB4 on carcinogenesis process remains unclear. In this study, we investigated the expression and roles of PSMB4 in multiple myeloma (MM). We found a significant up-regulation of PSMB4 in MM plasma and cell lines. Ectopic overexpression of PSMB4 promoted cell growth and colony forming ability of MM cells, whereas inhibition of PSMB4 led to a decrease of such events. Furthermore, our results demonstrated the up-regulation of miR-21 and a positive correlation between the levels of miR-21 and PSMB4 in MM. Re-expression of miR-21 markedly rescued PSMB4 knockdown-mediated suppression of cell proliferation and clone-formation. Additionally, while enforced expression of PSMB4 profoundly increased NF-κB activity and the level of miR-21, PSMB4 knockdown or NF-κB inhibition suppressed miR-21 expression in MM cells. Taken together, our results demonstrated that PSMB4 regulated MM cell growth in part by activating NF-κB-miR-21 signaling, which may represent promising targets for novel specific therapies. - Highlights: • First reported upregulation of PSMB4 in MM plasma and cell lines. • PSMB4 promoted MM cell growth and colony forming ability. • Further found miR-21 was up-regulated by PSMB4 in MM plasma and cell lines. • PSMB4-induced miR-21 expression was modulated by NF-κB. • PSMB4-NF-κB-miR-21 axis may be potential therapeutic targets of MM.

OSTI ID:
22458516
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 2 Vol. 458; ISSN 0006-291X; ISSN BBRCA9
Country of Publication:
United States
Language:
English

Similar Records

Sirt2 suppresses glioma cell growth through targeting NF-κB–miR-21 axis
Journal Article · Thu Nov 21 23:00:00 EST 2013 · Biochemical and Biophysical Research Communications · OSTI ID:22242198

SENP1 inhibition induces apoptosis and growth arrest of multiple myeloma cells through modulation of NF-κB signaling
Journal Article · Fri May 01 00:00:00 EDT 2015 · Biochemical and Biophysical Research Communications · OSTI ID:22462024

MiR-138 indirectly regulates the MDR1 promoter by NF-κB/p65 silencing
Journal Article · Fri Mar 10 23:00:00 EST 2017 · Biochemical and Biophysical Research Communications · OSTI ID:22696906